Jones DR - Search Results

1

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Yeung F, et al. Among authors: jones dr. EMBO J. 2004 Jun 16;23(12):2369-80. doi: 10.1038/sj.emboj.7600244. Epub 2004 May 20. EMBO J. 2004. PMID: 15152190 Free PMC article.

2

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.

Jones DR, Broad RM, Madrid LV, Baldwin AS Jr, Mayo MW. Jones DR, et al. Ann Thorac Surg. 2000 Sep;70(3):930-6; discussion 936-7. doi: 10.1016/s0003-4975(00)01635-0. Ann Thorac Surg. 2000. PMID: 11016336

3

PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit.

Mayo MW, Madrid LV, Westerheide SD, Jones DR, Yuan XJ, Baldwin AS Jr, Whang YE. Mayo MW, et al. Among authors: jones dr. J Biol Chem. 2002 Mar 29;277(13):11116-25. doi: 10.1074/jbc.M108670200. Epub 2002 Jan 17. J Biol Chem. 2002. PMID: 11799112 Free article.

4

Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation.

Jones DR, Broad RM, Comeau LD, Parsons SJ, Mayo MW. Jones DR, et al. J Thorac Cardiovasc Surg. 2002 Feb;123(2):310-7. doi: 10.1067/mtc.2002.118684. J Thorac Cardiovasc Surg. 2002. PMID: 11828291 Free article.

5

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway.

Mayo MW, Denlinger CE, Broad RM, Yeung F, Reilly ET, Shi Y, Jones DR. Mayo MW, et al. Among authors: jones dr. J Biol Chem. 2003 May 23;278(21):18980-9. doi: 10.1074/jbc.M211695200. Epub 2003 Mar 20. J Biol Chem. 2003. PMID: 12649266 Free article.

6

Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer.

Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR. Denlinger CE, et al. Among authors: jones dr. J Thorac Cardiovasc Surg. 2004 Apr;127(4):1078-86. doi: 10.1016/s0022-5223(03)01321-7. J Thorac Cardiovasc Surg. 2004. PMID: 15052205 Free article.

7

Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.

Rundall BK, Denlinger CE, Jones DR. Rundall BK, et al. Among authors: jones dr. Surgery. 2004 Aug;136(2):416-25. doi: 10.1016/j.surg.2004.05.018. Surgery. 2004. PMID: 15300209

8

Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB.

Denlinger CE, Rundall BK, Jones DR. Denlinger CE, et al. Among authors: jones dr. Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):28-39. doi: 10.1053/j.semtcvs.2003.12.004. Semin Thorac Cardiovasc Surg. 2004. PMID: 15366685 Review.

9

Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.

Denlinger CE, Rundall BK, Keller MD, Jones DR. Denlinger CE, et al. Among authors: jones dr. Ann Thorac Surg. 2004 Oct;78(4):1207-14; discussion 1207-14. doi: 10.1016/j.athoracsur.2004.04.029. Ann Thorac Surg. 2004. PMID: 15464472

10

Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.

Denlinger CE, Rundall BK, Jones DR. Denlinger CE, et al. Among authors: jones dr. J Thorac Cardiovasc Surg. 2004 Nov;128(5):740-8. doi: 10.1016/j.jtcvs.2004.07.010. J Thorac Cardiovasc Surg. 2004. PMID: 15514602 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,431 results

Search Page

Filters